Search
for
Sort by
Research 211–240 of 1000+
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Stem-cell therapy in dermatology – Challenges and opportunities
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- The JAK/STAT signaling pathway: from bench to clinic
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Steroid Responsive Mononeuritis Multiplex in the Cronkhite–Canada Syndrome
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Utilization of Stem Cells in Medicine: A Narrative Review
- Fresh Umbilical Cord Blood—A Source of Multipotent Stem Cells, Collection, Banking, Cryopreservation, and Ethical Concerns
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Mycosis Fungoides in Elderly Adults—A Diagnostic Challenge
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Review of Promising Off-Label Use of Deucravacitinib
- Subject Index
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- EMT Factors and Metabolic Pathways in Cancer
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Epigenetics of Colorectal Cancer
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases